Huangshi Shixing Pharmaceutical Co., Ltd. is located in Huangshi Economic and Technological Development Zone, National High-tech Zone. It covers an area of 117,266 square meters. It has 7 GMP production workshops and supporting facilities. The quality is at the world advanced level.
The company was formerly known as the Fourth Pharmaceutical Factory of Huangshi City. It was founded in 1992 and has a history of more than 20 years in the production of APIs. In 2003, the company conducted in-depth technical cooperation with Hubei Institute of Technology, and established the name of Huangshi Shixing Pharmaceutical Co., Ltd., and passed the GMP certification for the first time in 2005. In 2012, the company underwent shareholding reform and was controlled by Jinpai Co., Ltd. to form a new shareholding The company passed the new GMP certification in September 2015.
As a pharmaceutical company mainly engaged in R & D and production of raw materials, the company cooperates with many scientific research institutes such as Nanjing University, South-Central University for Nationalities, Hubei Institute of Technology and Hubei Medical College, etc. The company has an engineering center with advanced R & D conditions And a full-time technical R & D team, with strong process, product R & D and transformation of technological achievements, has many independent property rights, and many achievements have obtained major scientific and technological achievements in Hubei Province.
At present, the company has 11 kinds of APIs such as macrolides, antipyretics and analgesics, cardio-cerebrovascular, digestive system and anti-viral drugs. Its main products include erythromycin ethylsuccinate, etorubin, azithromycin , Roxithromycin, clarithromycin, dexketoprofen, dexketoprofen trometamol, milrinone, oxiracetam, lansoprazole, oxybenzazole hydrochloride and so on. With advanced technology, excellent quality and dedicated service, our products are sold all over the world.
CN
